Decentralized clinical trials have proven to allow continued recruitment and retention of patients, keeping trials and patient’s wellbeing on track, but what about keeping daily life on track for a patient and their family?
For rare disease patients, a clinical trial may be the important next step in their healthcare journey, an important key that unlocks the next door of treatment, so it’s imperative for those trial schedules to be flexible and meet the life needs of the patient. We know that a patient is more than their health condition — they’re parents, children, they go to school and work, they have a life outside of clinical research, and trial designs don’t always consider that.
MRN has spent close to two decades advocating for a decentralized, patient-focused approach to clinical trials, bringing trial visits to the patient in their own community. While the industry in recent years has discussed various decentralized, patient-centric strategies, COVID-19 brought their implementation to the very forefront of clinical trial development. As an industry, we saw sites close and studies lose their trial patients. Because of this, eyes have been opened to all of the possibilities decentralized solutions can bring to a trial, but with implementation comes a learning curve.
During this webinar, featured speakers will give you insights into their experience running decentralized trials so you can be ahead of the curve. They will discuss when decentralized trial visits will work, how to make them work, the impact on rare disease patients and families and how you can support them through decentralizing trials with a look into the journey of a family navigating life with a rare disease.
Caroline Potts, MSc Health Sciences, MSc Healthcare and Design, Senior Executive Director, Visit Management, Medical Research Network
Caroline has been instrumental in the delivery of decentralized clinical trials for over three years. In her current role as Senior Executive Director for Visit Management, she manages MRN’s global Project Management teams.
Before joining MRN, Caroline worked in the public sector for 15 years supporting research in hospitals and the primary care setting. She also provided support to research academics by writing funding applications, making submissions to regulatory authorities and running a large portfolio of studies to ICH-GCP requirements in clinical specialties such as stroke medicine, Parkinson’s disease, orthopaedics, gastrointestinal medicine and respiratory medicine. During this time, Caroline was one of the founding members of the UKRD group as well as an Executive member of the RD Forum providing R&D Directors and research staff working in the public sector with strategic guidance in supporting high-quality research in the NHS.Message Presenter
Tracey Murray, RGN, DipEd Nursing, BA(Hons) Health Studies, Director, Rare Disease Nurse Network
Tracey is a registered nurse with over 22 years’ experience of leading change and working within a variety of healthcare settings and roles. After specialising in Gerontology, she introduced a new workforce to Addenbrookes Hospital: Physician’s Assistants. She then joined the Norfolk, Suffolk and Cambridgeshire Strategic Health Authority as part of a team looking at Modernising the Medical Workforce.
Currently she is Matron of Outpatients at Cambridge University Hospitals NHS Foundation Trust, an active advocate for Rare Diseases — especially Sotos Syndrome, which her daughter has — and a director of The Rare Disease Nurse Network. Tracey describes the journey of living with a child with a rare disease as that of a roller coaster, travelling through a mixture of emotions, experiencing highs and lows, never truly knowing what to expect but cherishing every moment.Message Presenter
Who Should Attend?
- Chief Executive Officer
- Medical Director
- Clinical Development Director
- Clinical Operations
- Clinical Director
- Clinical Innovation
- Patient Engagement
- Patient Advocacy
- Patient Services
- Principal Investigator
- Clinical Trial Managers
- Study Coordinators
- Clinical Research Coordinators
What You Will Learn
Join this webinar for answers to key questions, such as:
- What are the real-life considerations for patients and families that need to be addressed when evaluating decentralized solutions?
- How do you achieve complete, quality data and maintain high quality of life for patients and families?
- Are decentralized solutions right for your trial and patient population? If so, how do you make decentralized solutions successful for your clinical trial?
Our focus is supporting clinical research delivery by helping patients participate in trials while remaining in their communities, wherever they live around the world. We aim to reduce the inconvenience and disruption of visits to investigator sites as much as feasible, by reducing the number of those visits. When visits need to be undertaken, we work to make the process as efficient and convenient as possible. We enhance patient enrolment, recruitment and retention.
As the largest international provider of specialist community clinical trial support, our services set the benchmarks for high-quality and innovative delivery. MRN is at the core of the clinical trial market and everything we do has always been focused on the patient.
Increased patient centricity is changing clinical research – This is, and always will be, a core part of Medical Research Network’s DNA.